- Yale Medicine has extensive experience treating pediatric leukemia.
- Our physicians use the most advanced and effective treatments for children with this cancer.
- Immunotherapy is playing an increasing role in our treatment of pediatric leukemia.
More than 50 years ago, it was rare for any child to survive childhood leukemia. Happily that situation has changed for the better. With advances in treatment, not only do children with the disease have an 85-to-90 percent survival rate, but many also go on to live happy, productive lives.
Leukemia is the most common type of childhood cancer that we treat at Yale Medicine, and one in which our physicians have extensive experience.